Waters’ Instruments Sales Slide 5 Percent in Q4 as Sales Slip 4 Percent

Waters officials this week said that its high-end mass specs, including the Synapt felt the sting of the tougher spending environment, though market adoption of the Acquity UPLC continued.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.